Lota S. Zoth's Net Worth

$596 Thousand

Estimate Recalculated Nov 3, 2024 09:40PM EST

Who is Lota S. Zoth?

Lota S. Zoth does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., HYPERION THERAPEUTICS INC, Zymeworks Inc., INOVIO PHARMACEUTICALS, INC., Spark Therapeutics, Inc., 89bio, Inc., LUMOS PHARMA, INC., Zymeworks Inc., MEDIMMUNE INC /DE, and enGene Holdings Inc..

SEC CIK

Lota S. Zoth's CIK is 0001278219

Past Insider Trading and Trends

2019 was Lota S. Zoth's most active year for acquiring shares with 16 total transactions. Lota S. Zoth's most active month to acquire stocks was the month of April. 2019 was Lota S. Zoth's most active year for disposing of shares, totalling 15 transactions. Lota S. Zoth's most active month to dispose stocks was the month of April. 2005 saw Lota S. Zoth paying a total of $0.00 for 75,000 shares, this is the most they've acquired in one year. In 2015 Lota S. Zoth cashed out on 38,201 shares for a total of $1,754,716.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Orexigen Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 14
Form 4
—
0
—
—
0
Jul 12
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Apr 26
Form 3
—
0
—
—
0
No matching records found

HYPERION THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.62K
$46.00
-$120,382.00
0
May 7
Form 4
∞
2.62K
—
—
2.62K
May 27
Form 4
—
0
—
—
0
Apr 15
Form 3
—
0
—
—
0
No matching records found

Zymeworks Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 6
Form 3
—
0
—
—
0
No matching records found

INOVIO PHARMACEUTICALS, INC. (INO) Snapshot price: $6.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 21
Form 4
+49.31%
2.17K
—
—
6.56K
May 15
Form 4
-9.76%
-5.70K
$0.56
-$3,192.00
52.72K
Jun 5
Form 4
+48.20%
19K
—
—
58.42K
May 15 - May 16
Form 4
+57.56%
14.4K
$1.98
-$7,128.00
39.42K
Scheduled
May 13 - May 16
Form 4
+14.30%
3.13K
$5.01
-$4,814.61
25.02K
Scheduled
Jan 3 - Jan 5
Form 4
+43.69%
6.66K
$6.62
-$13,537.90
21.89K
Scheduled
May 13 - May 17
Form 4
+25.85%
3.13K
$9.48
-$9,110.28
15.23K
Scheduled
Jan 3 - Jan 5
Form 4
—
0
—
—
0
May 14
Form 4
+195.92%
8.01K
—
—
12.1K
May 8
Form 4
∞
4.09K
—
—
4.09K
Jan 3
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
Jan 3
Form 3
—
0
—
—
0
No matching records found

Spark Therapeutics, Inc. No price found

CHIEF SCIENTIFIC OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.00K
$114.50
-$343,500.00
0
Dec 17
Form 4
+100.00%
1.5K
—
—
3K
May 30
Form 4
∞
1.5K
—
—
1.5K
May 30 - May 31
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jan 6
Form 3
—
0
—
—
0
No matching records found